China Health Group Inc. (FRA:VNL1)
Germany · Delayed Price · Currency is EUR 0.0070
0.00 (0.00%)
Last updated: Dec 18, 2025, 3:29 PM CET
China Health Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 29.78 | 26.45 | 21.43 | 13.09 | 83.6 | 83.06 | Upgrade |
| 29.78 | 26.45 | 21.43 | 13.09 | 83.6 | 83.06 | Upgrade | |
Revenue Growth (YoY) | 20.61% | 23.47% | 63.68% | -84.34% | 0.65% | 31.40% | Upgrade |
Cost of Revenue | 17.75 | 16.39 | 13.21 | 7.35 | 13.24 | 16.1 | Upgrade |
Gross Profit | 12.03 | 10.07 | 8.21 | 5.74 | 70.36 | 66.96 | Upgrade |
Selling, General & Admin | 10.48 | 10.08 | 7.61 | 13.97 | 21.39 | 11.89 | Upgrade |
Other Operating Expenses | -0.31 | -0.31 | -0 | -0.05 | -0 | -0.07 | Upgrade |
Operating Expenses | 24.97 | 24.57 | 65.54 | 21.75 | 28.27 | 11.82 | Upgrade |
Operating Income | -12.94 | -14.51 | -57.33 | -16.01 | 42.09 | 55.14 | Upgrade |
Interest Expense | - | - | - | -0.02 | -0.02 | -0.16 | Upgrade |
Interest & Investment Income | 0.08 | 0.06 | 0.12 | 0.2 | 0.43 | 0.23 | Upgrade |
Other Non Operating Income (Expenses) | -0.03 | -0.03 | -1 | - | - | - | Upgrade |
EBT Excluding Unusual Items | -12.89 | -14.47 | -58.21 | -15.83 | 42.5 | 55.21 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.02 | 15.59 | Upgrade |
Pretax Income | -12.89 | -14.47 | -58.21 | -15.83 | 42.52 | 70.8 | Upgrade |
Income Tax Expense | 0.28 | 0.05 | - | - | 6.2 | 10.15 | Upgrade |
Earnings From Continuing Operations | -13.17 | -14.52 | -58.21 | -15.83 | 36.33 | 60.65 | Upgrade |
Minority Interest in Earnings | - | - | 0.2 | - | - | - | Upgrade |
Net Income | -13.17 | -14.52 | -58.01 | -15.83 | 36.33 | 60.65 | Upgrade |
Net Income to Common | -13.17 | -14.52 | -58.01 | -15.83 | 36.33 | 60.65 | Upgrade |
Net Income Growth | - | - | - | - | -40.11% | 118.23% | Upgrade |
Shares Outstanding (Basic) | 995 | 995 | 995 | 995 | 995 | 994 | Upgrade |
Shares Outstanding (Diluted) | 995 | 995 | 995 | 995 | 995 | 997 | Upgrade |
Shares Change (YoY) | - | - | - | - | -0.18% | 0.44% | Upgrade |
EPS (Basic) | -0.01 | -0.01 | -0.06 | -0.02 | 0.04 | 0.06 | Upgrade |
EPS (Diluted) | -0.01 | -0.01 | -0.06 | -0.02 | 0.04 | 0.06 | Upgrade |
EPS Growth | - | - | - | - | -39.98% | 117.19% | Upgrade |
Free Cash Flow | 15.18 | 8.52 | -4.88 | -5.16 | -10.28 | 19.11 | Upgrade |
Free Cash Flow Per Share | 0.01 | 0.01 | -0.01 | -0.01 | -0.01 | 0.02 | Upgrade |
Gross Margin | 40.39% | 38.05% | 38.33% | 43.87% | 84.16% | 80.61% | Upgrade |
Operating Margin | -43.46% | -54.84% | -267.57% | -122.31% | 50.34% | 66.38% | Upgrade |
Profit Margin | -44.23% | -54.88% | -270.78% | -120.90% | 43.45% | 73.02% | Upgrade |
Free Cash Flow Margin | 50.97% | 32.22% | -22.79% | -39.39% | -12.29% | 23.01% | Upgrade |
EBITDA | -12.15 | -13.9 | -57.09 | -15.86 | 42.29 | 55.32 | Upgrade |
EBITDA Margin | -40.80% | -52.55% | -266.48% | -121.16% | 50.58% | 66.61% | Upgrade |
D&A For EBITDA | 0.79 | 0.61 | 0.23 | 0.15 | 0.2 | 0.18 | Upgrade |
EBIT | -12.94 | -14.51 | -57.33 | -16.01 | 42.09 | 55.14 | Upgrade |
EBIT Margin | -43.46% | -54.84% | -267.57% | -122.31% | 50.34% | 66.38% | Upgrade |
Effective Tax Rate | - | - | - | - | 14.57% | 14.33% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.